Search results for "Pseudomonas Aeruginosa"

showing 10 items of 158 documents

Effect of Bacteremia in Elderly Patients With Urinary Tract Infection.

2016

The clinical effect of bacteremia on outcomes in urinary tract infection (UTI) is still debated. This study aims to examine the clinical effect of bacteremia in elderly patients with UTI requiring hospital admission.This retrospective observational study recorded the clinical features, microbiology and outcomes in a Spanish cohort of patients aged ≥65 years hospitalized for UTI in whom blood cultures were performed in the emergency department. The primary outcome of the study was in-hospital mortality.Of 333 patients, with a mean age of 81.6 years, 137 (41.1%) had positive blood cultures. Escherichia coli, with 223 (66.9%) cases, was the most common microorganism isolated. Independent risk …

Malemedicine.medical_specialtyUrinary systemBacteremiaEnterococcus faecalisCohort Studies03 medical and health sciences0302 clinical medicineInternal medicinemedicineEnterococcus faecalisHumans030212 general & internal medicineEscherichia coli InfectionsRetrospective StudiesAged 80 and overbiologybusiness.industryMortality rate030208 emergency & critical care medicineRetrospective cohort studyGeneral MedicineOdds ratioEmergency departmentLength of Staybiology.organism_classificationmedicine.diseasePrognosisSurgeryCommunity-Acquired InfectionsLogistic ModelsSpainBacteremiaCohortPseudomonas aeruginosaUrinary Tract InfectionsFemalebusinessThe American journal of the medical sciences
researchProduct

Controlled Delivery of Gentamicin Antibiotic from Bioactive Electrospun Polylactide-Based Ultrathin Fibers

2011

The purpose of this study was to generate ultrathin fibers based on polylactide (PLA) biopolyester with antimicrobial controlled release capacity to treat bacterial infections. To achieve this objective, gentamicin antibiotic was encapsulated into pure PLA fibers, a blend of PLA–collagen and coaxial fibers containing a skin of PLA and a core of collagen using the electrospinning technique. The morphology of the gentamicin-loaded fibers and the antibiotic distribution within the fibers were examined by SEM and TEM. The drug delivery profile of the different electrospun fibers was analyzed using a spectrophotometric method. The performance for treating common possible post-surgical infections…

Materials sciencemedicine.drug_classPseudomonas aeruginosaAntibioticstechnology industry and agricultureCondensed Matter PhysicsAntimicrobialmedicine.disease_causeControlled releaseElectrospinningDrug deliverymedicineGeneral Materials ScienceGentamicinPolymer blendmedicine.drugBiomedical engineeringAdvanced Engineering Materials
researchProduct

Healthcare-Associated Pneumonia and Multidrug Resistant Bacteria: Do We Have a Convincing Answer?

2014

Methicillin-Resistant Staphylococcus aureusMicrobiology (medical)medicine.medical_specialtyBacteriabusiness.industryMedicine (all)Drug ResistanceBacterialPneumonia Ventilator-AssociatedBacteria; Enterobacteriaceae; Humans; Methicillin-Resistant Staphylococcus aureus; Pneumonia Ventilator-Associated; Pseudomonas aeruginosa; Drug Resistance Bacterial; Infectious Diseases; Microbiology (medical); Medicine (all)Pneumoniamedicine.diseasePneumoniaVentilator-AssociatedMultidrug resistant bacteriaInfectious DiseasesHealthcare associatedEnterobacteriaceaeDrug Resistance BacterialPseudomonas aeruginosamedicineBacteria; Enterobacteriaceae; Humans; Methicillin-Resistant Staphylococcus aureus; Pneumonia; Ventilator-Associated; Pseudomonas aeruginosa; Drug Resistance; Bacterial; Infectious Diseases; Microbiology (medical); Medicine (all)HumansIntensive care medicinebusiness
researchProduct

Synthesis, characterization, crystal structures and in vitro antistaphylococcal activity of organotin(IV) derivatives with 5,7-disubstituted-1,2,4-tr…

2011

Abstract New organotin(IV) complexes of 5,7-ditertbutyl-1,2,4-triazolo[1,5-a]pyrimidine ( dbtp ) and 5,7-diphenyl-1,2,4-triazolo[1,5-a]pyrimidine ( dptp ) with 1:1 and/or 1:2 stoichiometry were synthesized and investigated by X-ray diffraction, FT-IR and 119 Sn Mossbauer in the solid state and by 1 H and 13 C NMR spectroscopy, in solution. Moreover, the crystal and molecular structures of Et 2 SnCl 2 (dbtp) 2 and Ph 2 SnCl 2 (EtOH) 2 (dptp) 2 are reported. The complexes contain hexacoordinated tin atoms: in Et 2 SnCl 2 (dbtp) 2 two 5,7-ditertbutyl-1,2,4-triazolo[1,5-a]pyrimidine molecules coordinate classically the tin atom through N(3) atom and the coordination around the tin atom shows a …

Methicillin-Resistant Staphylococcus aureusTRIAZOLOPYRIMIDINE ORGANOTIN(IV)Staphylococcus aureusMagnetic Resonance SpectroscopyPyrimidineStereochemistrychemistry.chemical_elementOrganotin(IV)Crystal structureBiochemistryMedicinal chemistryInorganic Chemistrychemistry.chemical_compoundSpectroscopy MossbauerX-Ray DiffractionMössbauer spectroscopySpectroscopy Fourier Transform InfraredEscherichia coliOrganotin CompoundsMoleculeANTIMICROBIAL ACTIVITYTriazolopyrimidine; Organotin(IV); X-ray-structure; 119Sn Mössbauer; Antimicrobial activityCarbon-13 NMRTriazolesAnti-Bacterial AgentsTrigonal bipyramidal molecular geometryPyrimidineschemistryOctahedronSettore CHIM/03 - Chimica Generale E InorganicaPseudomonas aeruginosaTriazolopyrimidine119SN MÖSSBAUERTinX-RAY-STRUCTUREJournal of inorganic biochemistry
researchProduct

Combination of aztreonam, ceftazidime–avibactam and amikacin in the treatment of VIM-1 Pseudomonas aeruginosa ST235 osteomyelitis

2021

Abstract We describe a challenging case of patient with metallo-beta-lactamase-producing Pseudomonas aeruginosa sternal osteomyelitis following aortic valve replacement with biological prosthesis. The strain exhibited a multidrug-resistance phenotype carrying the blaVIM-1 gene and belonged to the high-risk clone sequence type ST235. The patient was successfully treated with surgical debridement plus antibiotic therapy with ceftazidime/avibactam, aztreonam, and amikacin. Time-kill curves showed that this triple antibiotic combination at 1 × MIC was strongly synergic after 8 h, achieving 99.9% killing and maintaining this until 48 h.

Microbiology (medical)AvibactamDrug ResistanceCeftazidimeInfectious and parasitic diseasesRC109-216Aztreonammedicine.disease_causeST235CeftazidimeMicrobiologyCeftazidime–avibactamchemistry.chemical_compoundAztreonamAortic valve replacementDrug TherapyDrug Resistance Multiple BacterialmedicineHumansPseudomonas InfectionsPseudomonas aeruginosa; ST235; VIM-1; aztreonam; ceftazidime-avibactam; osteomyelitisAmikacinAgedPseudomonas aeruginosabusiness.industryceftazidime-avibactamOsteomyelitisBacterialOsteomyelitisGeneral MedicineCeftazidime/avibactammedicine.diseaseAnti-Bacterial AgentsDrug CombinationsInfectious DiseaseschemistryDebridementAmikacinPseudomonas aeruginosaCombinationVIM-1Drug Therapy CombinationFemalebusinessAzabicyclo CompoundsMultiplemedicine.drug
researchProduct

Evaluation of the in-vitro cidal activity and toxicity of a novel peroxygen biocide: 2-butanone peroxide

2007

The monomer of 2-butanone peroxide is a novel peroxygen derivative with potential use as biocide in the hospital environment. The aim of this study was to test the biocidal activity of different concentrations of the compound against American Tissue Culture Collection strains from 11 different micro-organisms, including bacteria, mycobacteria, spores, fungi and virus, following the European Standard guidelines. Toxicity tests were also carried out following United States Environmental Protection Agency Standards. 2-Butanone peroxide exhibited biocidal activity at 0.12% against Legionella pneumophila, at 0.5% against Escherichia coli, Pseudomonas aeruginosa and Enterococcus hirae, and at 1% …

Microbiology (medical)BiocideMicrococcaceaeGuinea PigsGram-Positive Bacteriamedicine.disease_causePeroxideMicrobiologychemistry.chemical_compoundEnterococcus hiraeGram-Negative BacteriaToxicity TestsAnimalsMedicinebiologybusiness.industryPseudomonas aeruginosaBiological activityGeneral Medicinebiology.organism_classificationButanonesPeroxidesInfectious DiseaseschemistryStaphylococcus aureusToxicityRabbitsbusinessDisinfectantsJournal of Hospital Infection
researchProduct

Sepsis due to Erysipelothrix rhusiopathiae in a Patient with Chronic Lymphocytic Leukemia Associated with Bronchopneumonia due to PSeudomonas aerugin…

2015

Erysipelothrix rhusiopathiae infections can typically be attributed to exposure to animal products; thus, these infections are more common among farmers, butchers and veterinarians, among others. This article describes a case involving a 54-year-old man who had relative neutropenia subsequent to treatment for chronic lymphocytic leukemia. The patient developed E rhusiopathiae bacteremia with concomitant pneumonia. The author of this article suggests a likely route of infection, which is atypical considering the patient did not report exposure to animal products.

Microbiology (medical)Chronic lymphocytic leukemiaCase ReportBronchopneumoniaANIMAL EXPOSUREInfectious and parasitic diseasesRC109-216Erysipelothrix rhusiopathiaemedicine.disease_causeMicrobiologyMicrobiologySepsisSepsisMedicineEscherichia coliImmunocompromised hostbiologyErysipelothrix rhusiopathiaebusiness.industryPseudomonas aeruginosabiology.organism_classificationmedicine.diseaseQR1-502Infectious DiseasesConcomitantImmunologybusinessCanadian Journal of Infectious Diseases and Medical Microbiology
researchProduct

New β-Lactam-β-Lactamase Inhibitor Combinations.

2020

The limited armamentarium against drug-resistant Gram-negative bacilli has led to the development of several novel β-lactam-β-lactamase inhibitor combinations (BLBLIs). In this review, we summarize their spectrum of in vitro activities, mechanisms of resistance, and pharmacokinetic-pharmacodynamic (PK-PD) characteristics. A summary of available clinical data is provided per drug. Four approved BLBLIs are discussed in detail. All are options for treating multidrug-resistant (MDR) Enterobacterales and Pseudomonas aeruginosa Ceftazidime-avibactam is a potential drug for treating Enterobacterales producing extended-spectrum β-lactamase (ESBL), Klebsiella pneumoniae carbapenemase (KPC), AmpC, an…

Microbiology (medical)DrugImipenemBacilliEpidemiologyKlebsiella pneumoniaemedia_common.quotation_subjectMicrobial Sensitivity Testsmedicine.disease_causebeta-LactamsMeropenemMicrobiologyDrug Resistance Multiple BacterialGram-Negative Bacteriapolycyclic compoundsmedicinemedia_commonGeneral Immunology and MicrobiologybiologyPseudomonas aeruginosabusiness.industryPublic Health Environmental and Occupational Healthbiochemical phenomena metabolism and nutritionbacterial infections and mycosesbiology.organism_classificationCeftazidime/avibactamAcinetobacter baumanniiDrug CombinationsInfectious DiseasesbacteriaErratumbusinessbeta-Lactamase Inhibitorsmedicine.drugClinical microbiology reviews
researchProduct

On-Demand Isolation of Bacteriophages Against Drug-Resistant Bacteria for Personalized Phage Therapy

2015

Bacteriophages are bacterial viruses, capable of killing even multi-drug resistant bacterial cells. For this reason, therapeutic use of phages is considered as a possible alternative to conventional antibiotics. However, phages are very host specific in comparison to wide-spectrum antibiotics and thus preparation of phage-cocktails beforehand against pathogens can be difficult. In this study, we evaluate whether it may be possible to isolate phages on-demand from environmental reservoir. We attempted to enrich infectious bacteriophages from sewage against nosocomial drug-resistant bacterial strains of different medically important species in order to evaluate the probability of discovering …

Microbiology (medical)Phage cocktailsantibiotic resistancephage therapyPhage therapyKlebsiella pneumoniaevirusesmedicine.medical_treatmentlcsh:QR1-502MRSABiologyta3111medicine.disease_causeMicrobiologybakteriofagitlcsh:MicrobiologyMicrobiologyAntibiotic resistancephage cocktailsmedicineBacteriophagesVancomycin-resistant EnterococcusOriginal ResearchPseudomonas aeruginosata1183biology.organism_classificationVirologyMethicillin-resistant Staphylococcus aureusfagiterapia3. Good healthAcinetobacter baumanniiESBLBacterial virusantibioottiresistenssiFrontiers in Microbiology
researchProduct

Class 1 integrons in environmental and clinical isolates of Pseudomonas aeruginosa.

2011

The aims of this study were to ascertain the presence and spread of class 1 integrons amongst environmental and clinical isolates of Pseudomonas aeruginosa and to characterise their variable regions. A total of 76 isolates (56 clinical and 20 environmental) were studied. The presence of plasmids was explored, and polymerase chain reaction (PCR) was used for integron detection. All amplicons were sequenced. PCR detected class 1 integrons in 26 of the 56 clinical isolates; environmental isolates were integron-free. No plasmids were found, thus all the integrons found are possibly on the chromosome. Most isolates presented one amplicon, except PA110514 and PA116136, which showed two PCR produc…

Microbiology (medical)Transposable elementDNA BacterialMicrobial Sensitivity TestsBiologymedicine.disease_causeIntegronPolymerase Chain Reactionlaw.inventionMicrobiologyIntegronsPlasmidAntibiotic resistancelawDrug Resistance Multiple BacterialmedicineHumansPharmacology (medical)Pseudomonas InfectionsPolymerase chain reactionGeneticsPseudomonas aeruginosaGeneral Medicinebiochemical phenomena metabolism and nutritionAmpliconAnti-Bacterial AgentsBacterial Typing TechniquesInfectious DiseasesFomitesHorizontal gene transferPseudomonas aeruginosabiology.proteinbacteriaWater MicrobiologyPlasmidsInternational journal of antimicrobial agents
researchProduct